BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8705761)

  • 1. Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants.
    Gabler U; Berndt A; Kosmehl H; Mandel U; Zardi L; Müller S; Stelzner A; Katenkamp D
    Heart; 1996 Apr; 75(4):358-62. PubMed ID: 8705761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
    Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
    Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of fibronectin isoforms in human renal disease.
    Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
    J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
    Kriegsmann J; Berndt A; Hansen T; Borsi L; Zardi L; Bräuer R; Petrow PK; Otto M; Kirkpatrick CJ; Gay S; Kosmehl H
    Rheumatol Int; 2004 Jan; 24(1):25-33. PubMed ID: 12712258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries.
    Farnoud MR; Farhadian F; Samuel JL; Derome P; Peillon F; Li JY
    Int J Cancer; 1995 Mar; 61(1):27-34. PubMed ID: 7705930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.
    Berndt A; Kosmehl H; Mandel U; Gabler U; Luo X; Celeda D; Zardi L; Katenkamp D
    Histochem J; 1995 Dec; 27(12):1014-20. PubMed ID: 8789403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
    Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
    APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
    Franz M; Brehm BR; Richter P; Gruen K; Neri D; Kosmehl H; Hekmat K; Renner A; Gummert J; Figulla HR; Berndt A
    J Mol Histol; 2010 Feb; 41(1):39-50. PubMed ID: 20232238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of laminin alpha2 chain during normal and pathological growth of myocardium in rat and human.
    Oliviéro P; Chassagne C; Salichon N; Corbier A; Hamon G; Marotte F; Charlemagne D; Rappaport L; Samuel JL
    Cardiovasc Res; 2000 May; 46(2):346-55. PubMed ID: 10773239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.
    Franz M; Matusiak-Brückner M; Richter P; Grün K; Ziffels B; Neri D; Maschek H; Schulz U; Pfeil A; Jung C; Figulla HR; Gummert J; Berndt A; Renner A
    J Mol Histol; 2014 Oct; 45(5):519-32. PubMed ID: 24792713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of fibronectin during rat fetal and postnatal development: an in situ hybridisation and immunohistochemical study.
    Samuel JL; Farhadian F; Sabri A; Marotte F; Robert V; Rappaport L
    Cardiovasc Res; 1994 Nov; 28(11):1653-61. PubMed ID: 7842459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.
    Franz M; Grün K; Richter P; Brehm BR; Fritzenwanger M; Hekmat K; Neri D; Gummert J; Figulla HR; Kosmehl H; Berndt A; Renner A
    Histochem Cell Biol; 2010 Nov; 134(5):503-17. PubMed ID: 20931338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.
    Coito AJ; Brown LF; Peters JH; Kupiec-Weglinski JW; van de Water L
    Am J Pathol; 1997 May; 150(5):1757-72. PubMed ID: 9137099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
    Szotowski B; Goldin-Lang P; Antoniak S; Bogdanov VY; Pathirana D; Pauschinger M; Dörner A; Kuehl U; Coupland S; Nemerson Y; Hummel M; Poller W; Hetzer R; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2005 Apr; 45(7):1081-9. PubMed ID: 15808768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease.
    van der Straaten HM; Canninga-van Dijk MR; Verdonck LF; Castigliego D; Borst HP; Aten J; Fijnheer R
    J Invest Dermatol; 2004 Dec; 123(6):1057-62. PubMed ID: 15610514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin and fibronectin distribution in human normal and pathological synovium.
    Cutolo M; Picasso M; Ponassi M; Sun MZ; Balza E
    J Rheumatol; 1992 Sep; 19(9):1439-47. PubMed ID: 1279171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix components in dilated cardiomyopathy. Immunohistochemical study of endomyocardial biopsy specimens.
    Nogami K; Kusachi S; Nunoyama H; Kondo J; Endo C; Yamamoto K; Murakami T; Tsuji T
    Jpn Heart J; 1996 Jul; 37(4):483-94. PubMed ID: 8890762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of fibronectin isoforms after myocardial infarction in rats.
    Ulrich MM; Janssen AM; Daemen MJ; Rappaport L; Samuel JL; Contard F; Smits JF; Cleutjens JP
    J Mol Cell Cardiol; 1997 Sep; 29(9):2533-43. PubMed ID: 9299376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological and morphometric analysis of dilated cardiomyopathy with special reference to collagen IV expression.
    Jain P; Arava S; Seth S; Lalwani S; Ray R
    Indian J Pathol Microbiol; 2017; 60(4):481-486. PubMed ID: 29323059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.